Arndís F. Ólafsdóttir

university of gothenburg

H指数:14

被引数:1,418

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Diet and diet-related challenges with specific focus on carbohydrates and carbohydrate counting in adults with type 1 diabetes: a cross-sectional study

BMJ OPEN

IF2.3

2025-11-010

PRE

Systematic intensive therapy in addition to continuous glucose monitoring in adults with type 1 diabetes: a multicentre, open-label, randomised controlled trial

在1型糖尿病成人患者中实施系统强化治疗联合连续血糖监测：一项多中心、开放标签、随机对照试验

The Lancet Regional Health - Europe

IF0

2025-10-160

OAAI

Discordance between mean glucose and time in range in relation to HbA1c in individuals with type 1 diabetes: results from the GOLD and SILVER trials

DIABETOLOGIA

IF10.2

2024-04-261

OAAI

Design of a randomized cross-over study evaluating effects of carbohydrate intake on glycemic control in persons with type 1 diabetes

一项评估碳水化合物摄入对1型糖尿病患者血糖控制影响的随机交叉设计研究

FRONTIERS IN NUTRITION

IF5.1

2023-03-130

OAAI

Risk factors and incidence over time for lower extremity amputations in people with type 1 diabetes: an observational cohort study of 46,088 patients from the Swedish National Diabetes Registry

DIABETOLOGIA

IF10.2

2021-09-0816

OAAI

Risk Factors and Incidence over Time for Lower Extremity Amputations in Persons with Type 1 Diabetes: An Observational Cohort Study of 46,008 Patients from the Swedish National Diabetes Registry

DIABETES

IF7.5

2021-06-010

PRE

The majority of people with type 1 diabetes and multiple daily insulin injections benefit from using continuous glucose monitoring: An analysis based on the GOLD randomized trial (GOLD-5)

DIABETES OBESITY & METABOLISM

IF5.7

2020-12-109

OAAI

Sustained Intensive Treatment and Long-term Effects on HbA1c Reduction (SILVER Study) by CGM in People With Type 1 Diabetes Treated With MDI

DIABETES CARE

IF16.6

2020-11-1621

OAAI

Evaluation of Reference Metrics for Continuous Glucose Monitoring in Persons Without Diabetes and Prediabetes

无糖尿病和糖尿病前期人群连续血糖监测参考指标的评价

JOURNAL OF DIABETES SCIENCE AND TECHNOLOGY

IF3.7

2020-10-2617

OAAI

The Association Between HbA1cand Time in Hypoglycemia During CGM and Self-Monitoring of Blood Glucose in People With Type 1 Diabetes and Multiple Daily Insulin Injections: A Randomized Clinical Trial (GOLD-4)

DIABETES CARE

IF16.6

2020-07-0838

OAAI

Sustained Intensive Treatment and Long-Term Effects on A1C Reduction (SILVER Study) by CGM in Persons with T1D Treated with MDI

DIABETES

IF7.5

2020-06-011

PRE

HbA1c level as a risk factor for retinopathy and nephropathy in children and adults with type 1 diabetes: Swedish population based cohort study

BMJ-BRITISH MEDICAL JOURNAL

IF42.7

2019-08-28116

OAAI

Risk Factors for Atrial Fibrillation in People With Type 1 Diabetes: An Observational Cohort Study of 36,258 Patients From the Swedish National Diabetes Registry

DIABETES CARE

IF16.6

2019-06-0620

OAAI

Excess risk of lower extremity amputations in people with type 1 diabetes compared with the general population: amputations and type 1 diabetes

BMJ OPEN DIABETES RESEARCH & CARE

IF4.1

2019-04-1416

OAAI

A Randomized Clinical Trial of the Effect of Continuous Glucose Monitoring on Nocturnal Hypoglycemia, Daytime Hypoglycemia, Glycemic Variability, and Hypoglycemia Confidence in Persons with Type 1 Diabetes Treated with Multiple Daily Insulin Injections (GOLD-3)

连续血糖监测对每日多次注射胰岛素治疗的1型糖尿病患者夜间低血糖、日间低血糖、血糖变异性和低血糖信心的影响的随机临床试验 (GOLD-3)

DIABETES TECHNOLOGY & THERAPEUTICS

IF6.3

2018-04-0185

OAAI

A Clinical Trial of the Accuracy and Treatment Experience of the Flash Glucose Monitor FreeStyle Libre in Adults with Type 1 Diabetes

DIABETES TECHNOLOGY & THERAPEUTICS

IF6.3

2017-03-01131

OAAI

Continuous Glucose Monitoring vs Conventional Therapy for Glycemic Control in Adults With Type 1 Diabetes Treated With Multiple Daily Insulin Injections The GOLD Randomized Clinical Trial

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

IF55

2017-01-24525

PREAI

Arndís F. Ólafsdóttir

个人简介

教育背景

工作经历

荣誉奖项

研究方向